Russell Clayton
Chief Tech/Sci/R&D Officer presso LARIMAR THERAPEUTICS, INC.
Patrimonio netto: 170 775 $ in data 31/03/2024
Profilo
Russell G.
Clayton is currently the Chief Medical Officer at Larimar Therapeutics, Inc. He previously worked as the Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Vice President-Research & Development at Windtree Therapeutics, Inc., and Chief Medical Officer at Alcresta Therapeutics, Inc. He received his undergraduate degree from LaSalle University and his doctorate from Philadelphia College of Osteopathic Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 17/01/2024 | 22 500 ( 0.04% ) | 170 775 $ | 31/03/2024 |
Posizioni attive di Russell Clayton
| Società | Posizione | Inizio |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 17/07/2023 |
Precedenti posizioni note di Russell Clayton
| Società | Posizione | Fine |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Chief Tech/Sci/R&D Officer | 01/04/2017 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| WINDTREE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Russell Clayton
| LaSalle University | Undergraduate Degree |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Health Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
| Larimar Therapeutics, Inc. |
- Borsa valori
- Insiders
- Russell Clayton
